Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lessons Learned from the Feasibility Phase of the REvascularization CHoices Among Under-Represented Groups Evaluation (RECHARGE) Trial Program.

American heart journal·2026
Same author

Left Ventricular Ejection Fraction Trajectory and Long-Term Outcomes Following Percutaneous Coronary Intervention for Myocardial Infarction.

JACC. Advances·2026
Same author

Marked underutilization of lipoprotein(a) testing in peripheral artery disease: a national analysis of 8.3 million patients.

American journal of preventive cardiology·2026
Same author

Balloon Pulmonary Angioplasty for Treatment of Chronic Thromboembolic Pulmonary Hypertension: Statement From the BPA-CTEPH Alliance.

JACC. Cardiovascular interventions·2026
Same author

CalShock: beyond the shock team, building on California's cardiogenic shock system of care.

Heart failure reviews·2026
Same author

Use of Coronary Artery Calcium Scoring in Individuals With Elevated Lipoprotein(a): A Multicohort Study.

Journal of the American College of Cardiology·2026
Same journal

Life's essential 8 and its role in cardiovascular health: evolution, evidence, and future directions.

Expert review of cardiovascular therapy·2026
Same journal

Efficacy and safety of clopidogrel and aspirin initiated within 72 hours after mild ischemic stroke or high-risk TIA by sex: a prespecified subgroup analysis of the INSPIRES trial.

Expert review of cardiovascular therapy·2026
Same journal

Approaches to transcatheter aortic valve replacement failure: is more focus on prevention required?

Expert review of cardiovascular therapy·2026
Same journal

Vericiguat for heart failure with reduced ejection fraction: a perspective from approval to real-world clinical treatment.

Expert review of cardiovascular therapy·2026
Same journal

Early autonomic neuropathy in prediabetes: an overlooked driver of cardiometabolic risk.

Expert review of cardiovascular therapy·2026
Same journal

Contemporary approach and key considerations to asymptomatic aortic stenosis treatment.

Expert review of cardiovascular therapy·2026
See all related articles

Related Experiment Video

Updated: Feb 22, 2026

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

2.6K

Robotics in percutaneous cardiovascular interventions.

Ali Pourdjabbar1, Lawrence Ang1, Omid Behnamfar1

  • 1a Division of Cardiovascular Medicine , University of California, San Diego Sulpizio Cardiovascular Center , La Jolla , CA , USA.

Expert Review of Cardiovascular Therapy
|September 16, 2017
PubMed
Summary
This summary is machine-generated.

Robotic-assisted percutaneous cardiovascular interventions reduce radiation exposure for operators and patients. This technology shows promise for improved procedural accuracy and efficacy in coronary and peripheral vascular treatments.

Keywords:
Roboticscoronary artery diseasepercutaneous coronary interventionperipheral arterial diseaseradiation safety

More Related Videos

Robotic Ablation of Atrial Fibrillation
11:21

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

20.3K
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.7K

Related Experiment Videos

Last Updated: Feb 22, 2026

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

2.6K
Robotic Ablation of Atrial Fibrillation
11:21

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

20.3K
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.7K

Area of Science:

  • Interventional Cardiology
  • Medical Robotics
  • Cardiovascular Interventions

Background:

  • Percutaneous cardiovascular interventions traditionally require lead aprons due to radiation exposure.
  • Growing awareness of occupational hazards drives adoption of robotic technology in interventional cardiology.
  • Robotic systems offer a potential solution to mitigate risks associated with ionizing radiation.

Purpose of the Study:

  • To review the clinical outcomes of percutaneous robotic coronary and peripheral vascular interventions.
  • To assess the safety and feasibility of robotically-assisted cardiovascular procedures.
  • To evaluate the impact of robotic technology on operator and patient radiation exposure.

Main Methods:

  • Systematic literature review of percutaneous robotic cardiovascular interventions.
  • Analysis of studies reporting on coronary and peripheral vascular procedures.
  • Evaluation of clinical outcomes, safety, feasibility, and radiation exposure data.

Main Results:

  • Robotically-assisted interventions are safe and feasible for coronary and iliofemoral diseases.
  • Significant reduction in operator radiation exposure without compromising procedural success.
  • Potential patient benefits include accurate lesion measurement, precise stent placement, and reduced radiation dose.

Conclusions:

  • Robotically-assisted percutaneous cardiovascular interventions are validated and effective.
  • The technology significantly reduces operator radiation exposure.
  • Further research is needed to fully realize potential patient benefits and explore remote capabilities.